Anti-TNF antibody therapy for inflammatory bowel disease during pregnancy: A clinical review

Current Drug Targets

Volumn 11, Issue 2, 2010, Pages 234-241

  El Mourabet, Marwa ^a   El Hachem, Sandra ^a   Harrison, Janet R ^a   Binion, David G ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Adalimumab; Certolizumab pegol; Crohn's disease; Inflammatory bowel disease; Infliximab; Pregnancy; Ulcerative colitis

Indexed keywords

ADALIMUMAB; AMOXICILLIN PLUS CLAVULANIC ACID; AZATHIOPRINE; BALSALAZIDE; BUDESONIDE; CERTOLIZUMAB PEGOL; CORTICOSTEROID; CYCLOSPORIN; INFLIXIMAB; MERCAPTOPURINE; MESALAZINE; METHOTREXATE; METRONIDAZOLE; NATALIZUMAB; OLSALAZINE; QUINOLONE; RIFAXIMIN; SALAZOSULFAPYRIDINE; TACROLIMUS; THALIDOMIDE; TUMOR NECROSIS FACTOR INHIBITOR;

CROHN DISEASE; DISEASE ACTIVITY; DRUG SAFETY; ENTERITIS; FOOD AND DRUG ADMINISTRATION; GESTATION PERIOD; HUMAN; NONHUMAN; PREGNANCY; PREGNANCY OUTCOME; REMISSION; REVIEW; TERATOGENICITY; ULCERATIVE COLITIS;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77950832744     PISSN: 13894501     EISSN: None     Source Type: Journal    
DOI: 10.2174/138945010790309885     Document Type: Review

References (44)

1. Andres PG, Friedman LS. Epidemiology and the natural course of inflammatory bowel disease. Gastroenterol Clin North Am 1999; 28: 255-281 (Pubitemid 29306479)
2. Peyrin-Biroulet L, Deltenre, P, De Suray, N, Branche, J, Sandborn WJ, Colombel JF. Efficacy and safety of tumor necrosis factor antagonists in Crohn's disease: meta-analysis of placebo-controlled trials. Clin Gastroenterol Hepatol 2008; 6: 644. (Pubitemid 351783447)
3. Nielsen OH, Andreasson B, Bondesen S, Jacobsen O, Jarnum S. Pregnancy in Crohn's disease. Scand J Gastroenterol 1984; 19: 724-732
4. Nielsen OH, Andreasson B, Bondesen S, Jarnum S. Pregnancy in ulcerative colitis. Scand J Gastroenterol 1983; 18: 735-742
5. Dominitz JA, Young JC, Boyko EJ. Outcomes of infants born to mothers with inflammatory bowel disease: a population-based cohort study. Am J Gastroenterol 2002; 97: 641-648
6. Norgard B, Fonager K, Sorensen HT, Olsen J. Birth outcomes of women with ulcerative colitis: a nationwide Danish cohort study. Am J Gastroenterol 2000; 95: 3165-3170
7. Hanan IM KJ. Inflammatory bowel disease in the pregnant woman. Clin Perinatol 1985; 12: 669-682 (Pubitemid 16239284)
8. Miller JP. Inflammatory bowel disease in pregnancy: a review. J R Soc Med 1986; 79: 221-225 (Pubitemid 16118685)
9. Fonager K, Sorensen HT, Olsen J, Dahlerup JF, Rasmussen SN. Pregnancy outcome for women with Crohn's disease: a follow-up study based on linkage between national registries. Am J Gastroenterol 1998; 93: 2426-2430 (Pubitemid 29018549)
10. Kornfeld D, Cnattingius S, Ekbom A. Pregnancy outcomes in women with inflammatory bowel disease--a population-based cohort study. Am J Obstet Gynecol 1997; 177: 942-946 (Pubitemid 27516071)
11. Nguyen GC, Boudreau H, Harris ML, Maxwell CV. Outcomes of obstetric hospitalizations among women with inflammatory bowel disease in the United States. Clin Gastroenterol Hepatol 2009; 7: 329-334
12. Fedorkow DM, Persaud D, Nimrod CA. Inflammatory bowel disease: a controlled study of late pregnancy outcome. Am J Obstet Gynecol 1989; 160: 998-1001. (Pubitemid 19122592)
13. Reddy D, Murphy SJ, Kane SV, Present DH, Kornbluth AA. Relapses of inflammatory bowel disease during pregnancy: inhospital management and birth outcomes. Am J Gastroenterol 2008; 103: 1203-1209 (Pubitemid 351677969)
14. Mahadevan U, Sandborn WJ, Li DK, Hakimian S, Kane S, Corley DA. Pregnancy outcomes in women with inflammatory bowel disease: a large community-based study from Northern California. Gastroenterology 2007; 133: 1106-1112 (Pubitemid 47494456)
15. Dotan I, Alper A, Rachmilewitz D, Odes S, Chermesh I, Fraser G, et al. The effect of inflammatory bowel disease (IBD) during pregnancy on long term health and illness in children of patients - a multicenter Israeli study. J Crohn's Colitis 2009; 3: S24.
16. Caprilli R, Gassull MA, Escher JC, Moser G, Munkholm P, Forbes A, et al. European evidence based consensus on the diagnosis and management of Crohn's disease: special situations. Gut 2006; 55(Suppl 1: i36-58.
17. Diav-Citrin O, Park YH, Veerasuntharam G, Polachek H, Bologa M, Pastuszak A, et al. The safety of mesalamine in human pregnancy: a prospective controlled cohort study. Gastroenterology 1998; 114: 23-28
18. Targan SR, Hanauer SB, van Deventer SJ, Mayer L, Present DH, Braakman T, et al. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group. N Engl J Med 1997; 337: 1029-1035 (Pubitemid 27430520)
19. Gitlin D, Boesman M. Serum alpha-fetoprotein, albumin, and gamma-G-globulin in the human conceptus. J Clin Invest 1966; 45: 1826-1838
20. Simpson RA, Mayhew TM, Barnes PR. From 13 weeks to term, the trophoblast of human placenta grows by the continuous recruitment of new proliferative units: a study of nuclear number using the disector. Placenta 1992; 13: 501-512
21. Simister NE. Placental transport of immunoglobulin G. Vaccine 2003; 21: 3365-3369
22. Malek A, Sager R, Kuhn P, Nicolaides KH, Schneider H. Evolution of maternofetal transport of immunoglobulins during human pregnancy. Am J Reprod Immunol 1996; 36: 248-255 (Pubitemid 26383975)
23. Kane SV, Acquah LA. Placental transport of immunoglobulins: a clinical review for gastroenterologists who prescribe therapeutic monoclonal antibodies to women during conception and pregnancy. Am J Gastroenterol 2009; 104: 228-233
24. Vasiliauskas EA, Church JA, Silverman N, Barry M, Targan SR, Dubinsky MC. Case report: evidence for transplacental transfer of maternally administered infliximab to the newborn. Clin Gastroenterol Hepatol 2006; 4: 1255-1258 (Pubitemid 44512222)
25. Nesbitt A. Placental transfer and accumulation in milk of the anti-TNF antibody TN3 in rats: immunoglobulin G1 versus PEGylated Fab. The American journal of gastroenterology 2006; 101: 1119.
26. Miller RK, Mace K, Polliotti B, DeRita R, Hall W, Treacy G. Marginal transfer of ReoPro (Abciximab) compared with immunoglobulin G (F105), inulin and water in the perfused human placenta in vitro. Placenta 2003; 24: 727-738 (Pubitemid 37184795)
27. Kane S, Ford J, Cohen R, Wagner C. Absence of infliximab in infants and breast milk from nursing mothers receiving therapy for Crohn's disease before and after delivery. J Clin Gastroenterol 2009; 43: 613-616
28. Stengel JZ, Arnold HL. Is infliximab safe to use while breastfeeding? World J Gastroenterol 2008; 14: 3085-3087
29. Food and Drug Administration official website. [Online]. Available from: URL:www.fda.gov. Access date: October 3 2009.
30. Angelucci E, Cocco A, Viscido A, Caprilli R. Safe use of infliximab for the treatment of fistulizing Crohn's disease during pregnancy within 3 months of conception. Inflamm Bowel Dis 2008; 14: 435-436 (Pubitemid 351441340)
31. Bank L. Unexpected dramatic clinical response of psoriasis lesions and unexpected pregnancy in an infertile patient in response to treatment with anti-tumor necrosis factor monoclonal antibody for Crohn's disease. Am J Gastroenterol 2002; 97: S260.
32. James R. Successful treatment of pregnancy-triggered Crohn's disease complicated by severe recurrent life threatenting gastrointestinal bleeding. Am J Gastroenterol 2001; 96: S295.
33. Burt MJ, Frizelle FA, Barbezat GO. Pregnancy and exposure to infliximab (anti-tumor necrosis factor-alpha monoclonal antibody). J Gastroenterol Hepatol 2003; 18: 465-466 (Pubitemid 36549563)
34. Tursi A. Effect of intentional infliximab use throughout pregnancy in inducing and maintaining remission in Crohn's disease. Dig Liver Dis 2006; 38: 439-440 (Pubitemid 44356212)
35. Srinivasan R. Infliximab treatment and pregnancy outcome in active Crohn's disease. Am J Gastroenterol 2001; 96: 2274-2275 (Pubitemid 32660942)
36. Mahadevan U, Kane S, Sandborn WJ, Cohen RD, Hanson K, Terdiman JP, et al. Intentional infliximab use during pregnancy for induction or maintenance of remission in Crohn's disease. Aliment Pharmacol Ther 2005; 21: 733-738 (Pubitemid 40469001)
37. Katz JA, Antoni C, Keenan GF, Smith DE, Jacobs SJ, Lichtenstein GR. Outcome of pregnancy in women receiving infliximab for the treatment of Crohn's disease and rheumatoid arthritis. Am J Gastroenterol 2004; 99: 2385-2392 (Pubitemid 40039370)
38. Coburn LA, Wise PE, Schwartz DA. The successful use of adalimumab to treat active Crohn's disease of an ileoanal pouch during pregnancy. Dig Dis Sci 2006; 51: 2045-2047
39. Mishkin DS, Van Deinse W, Becker JM, Farraye FA. Successful use of adalimumab (Humira) for Crohn's disease in pregnancy. Inflamm Bowel Dis 2006; 12: 827-828 (Pubitemid 44253768)
40. Vesga L, Terdiman JP, Mahadevan U. Adalimumab use in pregnancy. Gut 2005; 54: 890.
41. Oussalah A, Bigard MA, Peyrin-Biroulet L. Certolizumab use in pregnancy. Gut 2009; 58: 608.
42. Organization of Teratology Information Specialists official website. [Online]. Available from: URL:www.otispregnancy.org. Access date: October 5 2009.
43. Hyrich KL Watson KD, Dixon WG, Silman AJ, Symmons DPM. Pregnancy experience in women with rheumatic diseases exposed to biologic agents: results from the BSR biologic register. Ann Rheum Dis 2006; 65 (Suppl 2): 321.
44. Administration FDA. Regulations. 1980, pp. 37434-37467